News

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...
Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsLee Roth - President, Burns McClellan, ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...